“Stick a fork in it (Generex), it’s done”

“Stick a fork in it (Generex), it’s done”

Motion to Approve (I) Stalking Horse Bid And Stalking Horse EPA; (II) Approving Bid Procedures And Bid Protections In Connection With The Sale of Debtor's Equity In Two Subsidiaries; (III) Approving The Form And Manner of Notice of Sale; (IV) Scheduling An Auction And Sale Hearing; and, Motion to Sell Free and Clear of Liens (Debtor's Equity In Two Subsidiaries) pursuant to 11 USC 363 f. [$188 Fee Amount] Filed by Trustee Marc P Barmat (Berger, Eyal)
https://www.bkalerts.com/recent-bankruptcy-ca...ology-corp.

Stalking Horse Bid: https://www.investopedia.com/terms/s/stalking...se%20price.

Questions:
Who is the Stalking Horse?
What is their bid?
Will others also bid and raise the price?
Is the bid high enough to pay off all the creditors?
Which two “Subsidiaries” are being sold? (Probably Nugenerex and Olaregen)
What is “Stalking Horse EPA”?

Results (if/when sale happens):
Generex stockholders have no say about the sale of the assets.
Generex will receive cash for their stock holdings.
If cash is greater than what is due creditors, then:
Generex could be liquidated and excess cash divided up among stockholders or
Generex remains as a “shell” company still on the OTC.
If cash is less than creditor debt, the cash will be divided among the creditors, Generex becomes nonexistent.
Any Nugenerex shareholders (assuming sale) will receive cash for their stock.

The saga of Generex/Nugenerex will fade into forgotten history.